Breaking News Instant updates and real-time market news.

ADRO

Aduro Biotech

$13.95

0.1 (0.72%)

08:01
11/21/16
11/21
08:01
11/21/16
08:01

Aduro Biotech announces LADD partial clinical hold lifted

Aduro Biotech announced that the FDA has lifted the partial clinical hold placed on its clinical trials evaluating the LADD immunotherapy platform, enabling patient enrollment to resume in all Aduro-sponsored clinical studies. In agreement with the FDA, Aduro's LADD-based clinical trial protocols have been modified to include extended patient surveillance, to exclude patients with certain prosthetic devices that are not easily removed, and to add guidance to administer prophylactic antibiotics following LADD-based treatment for patients who may receive immune-suppressive treatments.

ADRO Aduro Biotech
$13.95

0.1 (0.72%)

05/16/16
ROTH
05/16/16
NO CHANGE
Target $22
ROTH
Buy
Roth cuts Aduro target to $22, takes off Focus List
Roth Capital analyst Joseph Pantginis lowered his price target for Aduro Biotech to $22 from $46 and removed the stock from his firm's Focus List after the company announced that its Phase IIb study did not meet its overall survival endpoint in third-line and greater pancreatic cancer. The analyst keeps a Buy rating on Aduro, however, seeing upside from future pipeline contributions and signed partnerships with its Listeria-based LADD technology. The stock is down 18%, or $1.89, to $8.80 in afternoon trading.
05/17/16
ADAM
05/17/16
NO CHANGE
Target $30
ADAM
Buy
Aduro Biotech price target lowered to $30 from $43 at Canaccord
Canaccord lowered its price target on Aduro Biotech to $30 from $43 after its pancreatic cancer drug missed its primary endpoints in a Phase IIb study. The firm said there is potential for its STELLAR drug trial to still succeed, but lowered the probability and thus the price target. Canaccord maintained its Buy rating on Aduro Biotech shares.
05/17/16
JANY
05/17/16
NO CHANGE
Target $22
JANY
Buy
Aduro study failure has limited read-through to Advaxis, says Janney Capital
Janney Capital analyst Roy Buchanan said the failure of a trial Aduro Biotech's (ADRO) listeria-based immunotherapy candidate in advanced pancreatic cancer should have limited read-through to Advaxis' (ADXS) own listeria-based immunotherapy program. The lead indications for Advaxis, including HPV-driven cervical cancer, have good rationale that the HPV is causative, Buchanan tells investors. The analyst keeps a Buy rating and $22 fair value estimate on Advaxis shares.
10/25/16
ROTH
10/25/16
NO CHANGE
Target $20
ROTH
Buy
Aduro Biotech LADD platform takes another perception knock, says Roth Capital
Roth Capital analyst Joseph Pantginis says Aduro Biotech's LADD platform took another perception knock with a second case of a patient's treatment port testing positive for listeria. While there was no listeriosis/systemic impact to the patient and it resolved quickly, a partial clinical hold has been put in place with no new enrollment in LADD studies until protocols are modified with the FDA for increased surveillance. The analyst says his confidence remains high on the LADD platform and reiterates a Buy rating on the stock. Nonetheless, he lowered his price target on the shares to $20 from $22.

TODAY'S FREE FLY STORIES

USO

United States Oil Fund

$11.52

0.16 (1.41%)

13:21
02/23/17
02/23
13:21
02/23/17
13:21
Options
Large five-way spread in US Oil Fund as a position is adjusted »

Large five-way spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
02/23/17
02/23
13:20
02/23/17
13:20
General news
Treasury Action: yields remained at low ebb »

Treasury Action: yields…

SAGE

SAGE Therapeutics

$61.93

-2.13 (-3.33%)

13:19
02/23/17
02/23
13:19
02/23/17
13:19
Recommendations
SAGE Therapeutics analyst commentary  »

Leerink boosts SAGE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

$NSD

NASDAQ Market Internals

13:18
02/23/17
02/23
13:18
02/23/17
13:18
Technical Analysis
NASDAQ Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:18
02/23/17
02/23
13:18
02/23/17
13:18
Technical Analysis
NYSE Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$45.35

0.34 (0.76%)

, STJ

Acquired by ABT

13:16
02/23/17
02/23
13:16
02/23/17
13:16
Hot Stocks
FTC approves order settling charges that Abbott-St. Jude deal is anticompetitive »

Following a public…

ABT

Abbott

$45.35

0.34 (0.76%)

STJ

Acquired by ABT

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 17

    Mar

CMI

Cummins

$149.46

-2.788 (-1.83%)

13:16
02/23/17
02/23
13:16
02/23/17
13:16
Options
Cummins put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

13:15
02/23/17
02/23
13:15
02/23/17
13:15
General news
Treasury's $28 B 7-year auction results were mixed but generally good »

Treasury's $28 B…

KO

Coca-Cola

$41.91

0.31 (0.75%)

13:09
02/23/17
02/23
13:09
02/23/17
13:09
Hot Stocks
Coca-Cola: End of refranchising 'in sight' »

Says it would be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 09

    May

13:04
02/23/17
02/23
13:04
02/23/17
13:04
General news
7-Yr Note Auction Coupon Rate data reported »

7-Yr Note Auction Coupon…

13:04
02/23/17
02/23
13:04
02/23/17
13:04
General news
7-Yr Note Auction Total Amount data reported »

7-Yr Note Auction Total…

P

Pandora

$13.13

0.18 (1.39%)

13:01
02/23/17
02/23
13:01
02/23/17
13:01
Options
Repeat interest in Pandora June spreads »

Repeat interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

  • 19

    Mar

ICBK

County Bancorp

$27.77

-0.63 (-2.22%)

13:00
02/23/17
02/23
13:00
02/23/17
13:00
Hot Stocks
County Bancorp boosts quarterly dividend to 6c from 5c »

County Bancorp earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

KO

Coca-Cola

$41.95

0.345 (0.83%)

12:58
02/23/17
02/23
12:58
02/23/17
12:58
Hot Stocks
Breaking Hot Stocks news story on Coca-Cola »

Coca-Cola says supports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 09

    May

CNX

CONSOL

$16.70

-0.34 (-2.00%)

12:56
02/23/17
02/23
12:56
02/23/17
12:56
Options
CONSOL put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RWLK

ReWalk Robotics

$2.35

0.05 (2.17%)

12:55
02/23/17
02/23
12:55
02/23/17
12:55
Hot Stocks
ReWalk Robotics awarded $1.2M Department of Veterans Affairs contract 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

THG

Hanover Insurance

$91.75

0.67 (0.74%)

12:53
02/23/17
02/23
12:53
02/23/17
12:53
Hot Stocks
Hanover Insurance outlines go-forward strategy at investor day »

The Hanover Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 05

    Mar

GLT

Glatfelter

$23.02

0.12 (0.52%)

12:52
02/23/17
02/23
12:52
02/23/17
12:52
Hot Stocks
Glatfelter board raises quarterly dividend 4% to 13c per share »

Glatfelter announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

KO

Coca-Cola

$41.99

0.385 (0.93%)

12:50
02/23/17
02/23
12:50
02/23/17
12:50
Hot Stocks
Coca-Cola COO: Company needs to reshape growth equation for sparkling segment »

Says needs to reshape…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 09

    May

LMT

Lockheed Martin

$264.79

-1.13 (-0.42%)

12:49
02/23/17
02/23
12:49
02/23/17
12:49
Hot Stocks
Lockheed Martin awards new contract to IBC Advanced Alloys for F-35 parts »

IBC Advanced Alloys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CL

Colgate-Palmolive

$74.80

1.31 (1.78%)

12:46
02/23/17
02/23
12:46
02/23/17
12:46
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TSLA

Tesla

$273.51

-3.88 (-1.40%)

, HPQ

HP Inc.

$17.64

1.435 (8.86%)

12:45
02/23/17
02/23
12:45
02/23/17
12:45
General news
On The Fly: Top stock stories at midday »

Stocks began the session…

TSLA

Tesla

$273.51

-3.88 (-1.40%)

HPQ

HP Inc.

$17.64

1.435 (8.86%)

NVDA

NVIDIA

$110.76

-0.31 (-0.28%)

LB

Labarge

$49.44

-8.69 (-14.95%)

SQ

Square

$17.13

2.0858 (13.87%)

CRI

Carter's

$87.79

4.21 (5.04%)

ACM

AECOM

$36.51

-1.48 (-3.90%)

JEC

Jacobs Engineering

$56.08

-0.72 (-1.27%)

KBR

KBR

$16.02

-0.32 (-1.96%)

CBI

CB&I

$33.75

-0.97 (-2.79%)

STLD

Steel Dynamics

$37.37

-0.22 (-0.59%)

AKS

AK Steel

$8.23

-0.56 (-6.37%)

X

U.S. Steel

$37.74

-2.75 (-6.79%)

FLR

Fluor

$55.63

-0.97 (-1.71%)

GVA

Granite Construction

$52.20

-2.115 (-3.89%)

VMC

Vulcan Materials

$116.45

-3.69 (-3.07%)

PWR

Quanta Services

$36.88

-0.7782 (-2.07%)

MTZ

MasTec

$36.50

-1 (-2.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 24

    Feb

  • 24

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 07

    Mar

  • 16

    Mar

  • 17

    Apr

12:45
02/23/17
02/23
12:45
02/23/17
12:45
General news
Breaking General news story  »

Dallas Federal Reserve…

VRTU

Virtusa

$28.80

-0.06 (-0.21%)

12:42
02/23/17
02/23
12:42
02/23/17
12:42
Conference/Events
Virtusa management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

  • 07

    Mar

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 27

    Mar

  • 28

    Mar

GOOG

Alphabet

$830.76

-0.9 (-0.11%)

, GOOGL

Alphabet Class A

$851.36

2.09 (0.25%)

12:42
02/23/17
02/23
12:42
02/23/17
12:42
Hot Stocks
Google Fiber launches 'Webpass' wireless service in Denver »

Google Fiber announced…

GOOG

Alphabet

$830.76

-0.9 (-0.11%)

GOOGL

Alphabet Class A

$851.36

2.09 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.